CoChat

Stable XIAP knockdown clones of HCT116 colon cancer cells are more sensitive to TRAIL, taxanes and irradiation in vitro

Connolly, Kate, Mitter, Richard, Muir, Morwenna, Jodrell, Duncan, Guichard, Sylvie · 2009 · Cancer Chemotherapy and Pharmacology

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Abstract

Purpose To develop a model of X-linked inhibitor of apoptosis (XIAP) down regulation in colorectal cancer cell lines. This may be used to determine whether combination strategies have clinical potential.Methods A series of clones were developed using short hairpin RNA (shRNA) against XIAP stably expressed in HCT116 cells. XIAP mRNA and protein levels were established by RT-PCR and Immunoblot, respectively. GeneChip microarrays confirmed XIAP knockdown and absence of compensation by other IAP members.Results Four XIAP knockdown cell lines show 82-93% reduction in XIAP mRNA and 67-89% reduction in protein when compared to four luciferase control cell lines. XIAP knockdown sensitises cells to rhTRAIL by a factor of 3, to paclitaxel and docetaxel by a factor of >2 and, to a lesser extent, radiotherapy (20% enhancement).Conclusions Clinical trials with XIAP antisense continue, and these data suggest combination studies with agents such as rhTRAIL and taxanes should be undertaken.

Overview

Integrity signals

Registry

Crossref · 10.1007/s00280-008-0872-x

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 49 references

Research works printed but not linked: 1

  1. Ranson M, Ward T, Cummings J et al (2005) A Phase 1 Trial of AEG35156 (XIAP antisense) administered as a 7-day continuous intravenous infusion in patients with advanced tumors. Clin Cancer Res 11(24, Part 2):8965s–9216s

Cited by

See all 35

Metadata

Authors
Connolly, K., Mitter, R., Muir, M., Jodrell, D., & Guichard, S.
Affiliations
  • Edinburgh Cancer Research (GB)
  • Cancer Research UK (GB)
  • University of Cambridge (GB)
  • AstraZeneca (United Kingdom) (GB)
Corresponding author
Connolly, Kate
Venue
Cancer Chemotherapy and Pharmacology
Published
2008-11-26
Volume
64
Issue
2
Pages
307-316
ISSN
  • 0344-5704 (ISSN-L)
  • 1432-0843
OpenAlex
W2001633094
Cited by
34
References
49
Citations by year
2023: 1 · 2022: 2 · 2021: 3 · 2020: 1 · 2019: 2 · 2017: 1 · 2016: 2 · 2015: 1 · 2014: 1 · 2013: 5 · 2012: 5
FWCI
1.37
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Cancer Chemotherapy and Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Cancer Research UK (C96/A4743)
  • University of Manchester
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
Keywords
XIAP, X-linked inhibitor of apoptosis, HCT116 cells, colorectal cancer, shRNA, gene knockdown, TRAIL, paclitaxel, docetaxel, radiosensitization, apoptosis inhibitor, combination therapy
MeSH terms
Animals, Colonic Neoplasms, Flow Cytometry, Gamma Rays, Humans, Mice, Nude, RNA, Messenger, Tumor Cells, Cultured, Immunoblotting, Reverse Transcriptase Polymerase Chain Reaction, Caspases, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Xenograft Model Antitumor Assays, RNA, Small Interfering, Taxoids, Cell Proliferation, Mice, X-Linked Inhibitor of Apoptosis Protein, TNF-Related Apoptosis-Inducing Ligand, Gene Knockdown Techniques, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.